John Maraganore's Net Worth
John Maraganore's net worth is estimated to be at least $118,801,239.17 as of 12/23/2024. CoreStreet's estimation of John Maraganore's net worth is based on their sale of stock and current holding of stock.
John Maraganore is CEO at Alnylam Pharmaceuticals Inc. They have executed at least 31 trades of stock as per SEC Form 4 filings. Their most recent trade was for 33,978 units of ALNY stock on 11/12/2021. Their biggest sale was on 11/22/2017 when they sold 73,415 units of Alnylam Pharmaceuticals Inc stock for $9,610,023.50. They typically trade 3 times per year.
Total value of insider buys:
- $1,650,082.50
Total value of insider sells:
- $117,151,156.67
Most recent insider trade:
- Nov. 12, 2021
John Maraganore's Insider Trading History
| Alnylam Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 12, 2021 | CEO | 33,978 | $171.52 | Sell | $5,827,906.56 |
Aug. 13, 2021 | CEO | 33,979 | $199.78 | Sell | $6,788,324.62 |
May 13, 2021 | CEO | 33,979 | $130.78 | Sell | $4,443,773.62 |
Aug. 20, 2020 | CEO | 34,765 | $136.13 | Sell | $4,732,559.45 |
May 20, 2020 | CEO | 34,765 | $143.22 | Sell | $4,979,043.30 |
Feb. 20, 2020 | CEO | 34,765 | $131.85 | Sell | $4,583,765.25 |
Oct. 14, 2019 | CEO | 49,456 | $79.45 | Sell | $3,929,279.20 |
May 15, 2019 | CEO | 49,457 | $70.00 | Sell | $3,461,990.00 |
July 25, 2018 | CEO | 50,000 | $105.39 | Sell | $5,269,500.00 |
Nov. 22, 2017 | CEO | 73,415 | $130.90 | Sell | $9,610,023.50 |
Nov. 15, 2017 | CEO | 74,000 | $126.86 | Sell | $9,387,640.00 |
July 20, 2016 | CEO | 30,151 | $64.69 | Sell | $1,950,468.19 |
April 20, 2016 | CEO | 30,151 | $67.46 | Sell | $2,033,986.46 |
Jan. 20, 2016 | CEO | 30,152 | $71.78 | Sell | $2,164,310.56 |
Dec. 2, 2015 | CEO | 58,689 | $104.87 | Sell | $6,154,715.43 |
Nov. 20, 2015 | CEO | 58,690 | $102.88 | Sell | $6,038,027.20 |
Jan. 26, 2015 | CEO | 10,000 | $95.00 | Buy | $950,000.00 |
Sept. 18, 2014 | CEO | 113,668 | $77.71 | Sell | $8,833,140.28 |
June 26, 2014 | CEO | 113,668 | $65.45 | Sell | $7,439,570.60 |
May 15, 2014 | CEO | 113,668 | $56.73 | Sell | $6,448,385.64 |
Sept. 11, 2013 | CEO | 58,947 | $55.50 | Sell | $3,271,558.50 |
Aug. 14, 2013 | CEO | 60,000 | $48.97 | Sell | $2,938,200.00 |
July 10, 2013 | CEO | 60,000 | $37.11 | Sell | $2,226,600.00 |
| Agios Pharm | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 11, 2018 | Director | 13,555 | $72.75 | Sell | $986,126.25 |
Dec. 16, 2014 | Director | 1,806 | $110.75 | Buy | $200,014.50 |
June 23, 2014 | Director | 2,300 | $43.98 | Buy | $101,154.00 |
April 29, 2014 | Director | 2,250 | $44.00 | Buy | $99,000.00 |
| Bluebird bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 14, 2017 | Director | 18,868 | $131.21 | Sell | $2,475,670.28 |
March 3, 2017 | Director | 13,839 | $85.02 | Sell | $1,176,591.78 |
Dec. 19, 2014 | Director | 2,352 | $85.00 | Buy | $199,920.00 |
July 14, 2014 | Director | 2,941 | $34.00 | Buy | $99,994.00 |